000 01463 a2200349 4500
005 20250516030558.0
264 0 _c20110825
008 201108s 0 0 eng d
022 _a1439-4286
024 7 _a10.1055/s-0031-1273682
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFröhlich, E
245 0 0 _aDecrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
_h[electronic resource]
260 _bHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
_cMay 2011
300 _a364-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma, Follicular
_xenzymology
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aDipeptidyl Peptidase 4
_xgenetics
650 0 4 _aDown-Regulation
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLovastatin
_xpharmacology
650 0 4 _aThyroid Neoplasms
_xenzymology
650 0 4 _aVitamin A
_xpharmacology
700 1 _aEngel, E
700 1 _aWahl, R
773 0 _tHormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
_gvol. 43
_gno. 5
_gp. 364-6
856 4 0 _uhttps://doi.org/10.1055/s-0031-1273682
_zAvailable from publisher's website
999 _c20683622
_d20683622